SGLT2i was found to attenuate the growth of thyroid cancer cells in vitro and in vivo, and its mechanism may include 1) inhibiting the level of glucose uptake and glycolysis, suppressing the activation of AKT/mTOR, and increasing the activation of AMPK, which inhibited the growth of thyroid cancer cells. Here, MTOR is linked to thyroid gland carcinoma.